Abstract:
Objective To investigate the effects and mechanisms of Yiqi Wenyang Huoxue Decoction on oxidative stress injury in rats with chronic heart failure (CHF).
Methods A CHF rat model was established using the abdominal aortic constriction method. The rats were divided into sham-operated group (n=10), CHF group (n=10), low-dose Yiqi Wenyang Huoxue Decoction group (n=10), medium-dose Yiqi Wenyang Huoxue Decoction group (n=10) and high-dose Yiqi Wenyang Huoxue Decoction group (n=10). Cardiac structure and functional parameters were measured in each group, including left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), left ventricular fractional shortening (LVFS) and left ventricular ejection fraction (LVEF). Oxidative stress indicators were detected in each group, including glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), malondialdehyde (MDA) and catalase (CAT). Cardiac injury markers were evaluated in each group, including creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH). Hematoxylin-eosin staining and Masson staining were used to observe cardiomyocyte morphology and myocardial fibrosis. TUNEL staining was employed to observe cardiomyocyte apoptosis. Western blotting was utilized to analyze the expression of proteins related to the ERK/Nrf2 signaling pathway.
Results The LVESD and LVEDD in the CHF group were significantly larger than those in the sham-operated group, while LVEF and LVFS were significantly lower (P < 0.05). The LVESD and LVEDD in the low-dose, medium-dose and high-dose Yiqi Wenyang Huoxue Decoction groups were significantly smaller than those in the CHF group, while LVEF and LVFS were significantly higher (P < 0.05). The serum levels of SOD, GSH-Px and CAT in the CHF group were significantly lower than those in the sham-operated group, while the MDA level was significantly higher (P < 0.05). The SOD, GSH-Px and CAT levels in the low-dose, medium-dose and high-dose Yiqi Wenyang Huoxue Decoction groups were significantly higher than those in the CHF group, while the MDA level was significantly lower (P < 0.05). The serum levels of CK-MB, and LDH in the CHF group were significantly higher than those in the sham-operated group (P < 0.05). The CK-MB, and LDH levels in the low-dose, medium-dose and high-dose Yiqi Wenyang Huoxue Decoction groups were significantly lower than those in the CHF group (P < 0.05). The treatment groups with Yiqi Wenyang Huoxue Decoction significantly inhibited cardiomyocyte apoptosis, improved cardiomyocyte morphology, and reduced myocardial fibrosis. Western blotting analysis revealed that Yiqi Wenyang Huoxue Decoction significantly upregulated the phosphorylation level of ERK protein and the expression of Nrf2.
Conclusion Yiqi Wenyang Huoxue Decoction may alleviate oxidative stress injury in a rat model of CHF via the ERK/Nrf2 signaling pathway.